Robert A. Bradway
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2013-01-01
- Valid until
- still holds
- Published
- 2026-04-07
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Robert A. Bradway has served as our director since 2011 and Chairman of the Board since 2013.”— what the page says, read 2026-11-08
Cite this claim
Plain text
AsOf. "Amgen chair: Robert A. Bradway", as of 2013-01-01. Claim clm_3662BB7CA128, https://asof.is/claim/clm_3662BB7CA128, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm.
APA
AsOf. (2013). Amgen chair: Robert A. Bradway (as of 2013-01-01) [Record clm_3662BB7CA128]. Retrieved November 9, 2026, from https://asof.is/claim/clm_3662BB7CA128 (source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm)
BibTeX
@misc{asof_clm_3662BB7CA128,
author = {AsOf},
title = {Amgen chair: Robert A. Bradway},
year = {2013},
howpublished = {\url{https://asof.is/claim/clm_3662BB7CA128}},
note = {Claim clm\_3662BB7CA128, as of 2013-01-01; source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm},
urldate = {2026-11-09}
}On the record
/claim/clm_3662BB7CA128.md/v1/claims/clm_3662BB7CA128submit a correction